JANICE BASS: Open Payments
NPI 1639117963 · MANCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 57 payments from 15 companies in 2025. Trend: 2023 $1,248 · 2024 $1,085 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| ABBVIE INC. | 12 | $135 |
| Lilly USA, LLC | 7 | $118 |
| PFIZER INC. | 6 | $108 |
| Novo Nordisk Inc | 5 | $97 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: ELIQUIS, MOUNJARO, VRAYLAR, AIRSUPRA, Ozempic, FARXIGA, UBRELVY, CAPLYTA.
Industry payments across TN — which companies pay providers there.
